162 related articles for article (PubMed ID: 31152393)
1. Optimization of Metabolic Labeling with Alkyne-Containing Isoprenoid Probes.
Ahmadi M; Suazo KF; Distefano MD
Methods Mol Biol; 2019; 2009():35-43. PubMed ID: 31152393
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Labeling of Prenylated Proteins Using Alkyne-Modified Isoprenoid Analogues.
Suazo KF; Hurben AK; Liu K; Xu F; Thao P; Sudheer C; Li L; Distefano MD
Curr Protoc Chem Biol; 2018 Sep; 10(3):e46. PubMed ID: 30058775
[TBL] [Abstract][Full Text] [Related]
3. Synthetic isoprenoid analogues for the study of prenylated proteins: Fluorescent imaging and proteomic applications.
Wang YC; Distefano MD
Bioorg Chem; 2016 Feb; 64():59-65. PubMed ID: 26709869
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells.
Palsuledesai CC; Ochocki JD; Kuhns MM; Wang YC; Warmka JK; Chernick DS; Wattenberg EV; Li L; Arriaga EA; Distefano MD
ACS Chem Biol; 2016 Oct; 11(10):2820-2828. PubMed ID: 27525511
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.
DeGraw AJ; Palsuledesai C; Ochocki JD; Dozier JK; Lenevich S; Rashidian M; Distefano MD
Chem Biol Drug Des; 2010 Dec; 76(6):460-71. PubMed ID: 21040496
[TBL] [Abstract][Full Text] [Related]
6. Metabolic labeling with an alkyne probe reveals similarities and differences in the prenylomes of several brain-derived cell lines and primary cells.
Suazo KF; Jeong A; Ahmadi M; Brown C; Qu W; Li L; Distefano MD
Sci Rep; 2021 Feb; 11(1):4367. PubMed ID: 33623102
[TBL] [Abstract][Full Text] [Related]
7. a-Factor Analogues Containing Alkyne- and Azide-Functionalized Isoprenoids Are Efficiently Enzymatically Processed and Retain Wild-Type Bioactivity.
Diaz-Rodriguez V; Hsu ET; Ganusova E; Werst ER; Becker JM; Hrycyna CA; Distefano MD
Bioconjug Chem; 2018 Feb; 29(2):316-323. PubMed ID: 29188996
[TBL] [Abstract][Full Text] [Related]
8. A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins.
Palsuledesai CC; Ochocki JD; Markowski TW; Distefano MD
Mol Biosyst; 2014 May; 10(5):1094-103. PubMed ID: 24577581
[TBL] [Abstract][Full Text] [Related]
9. A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting.
Onono FO; Morgan MA; Spielmann HP; Andres DA; Subramanian T; Ganser A; Reuter CW
Mol Cell Proteomics; 2010 Apr; 9(4):742-51. PubMed ID: 20103566
[TBL] [Abstract][Full Text] [Related]
10. Protein prenylation: enzymes, therapeutics, and biotechnology applications.
Palsuledesai CC; Distefano MD
ACS Chem Biol; 2015 Jan; 10(1):51-62. PubMed ID: 25402849
[TBL] [Abstract][Full Text] [Related]
11. Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.
Brioschi M; Martinez Fernandez A; Banfi C
Expert Rev Proteomics; 2017 Jun; 14(6):515-528. PubMed ID: 28521569
[TBL] [Abstract][Full Text] [Related]
12. A tagging-via-substrate technology for detection and proteomics of farnesylated proteins.
Kho Y; Kim SC; Jiang C; Barma D; Kwon SW; Cheng J; Jaunbergs J; Weinbaum C; Tamanoi F; Falck J; Zhao Y
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12479-84. PubMed ID: 15308774
[TBL] [Abstract][Full Text] [Related]
13. Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics.
Storck EM; Morales-Sanfrutos J; Serwa RA; Panyain N; Lanyon-Hogg T; Tolmachova T; Ventimiglia LN; Martin-Serrano J; Seabra MC; Wojciak-Stothard B; Tate EW
Nat Chem; 2019 Jun; 11(6):552-561. PubMed ID: 30936521
[TBL] [Abstract][Full Text] [Related]
14. Protein prenylation and synaptic plasticity: implications for Alzheimer's disease.
Hottman DA; Li L
Mol Neurobiol; 2014 Aug; 50(1):177-85. PubMed ID: 24390573
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases.
Zhang Y; Blanden MJ; Sudheer Ch; Gangopadhyay SA; Rashidian M; Hougland JL; Distefano MD
Bioconjug Chem; 2015 Dec; 26(12):2542-53. PubMed ID: 26561785
[TBL] [Abstract][Full Text] [Related]
16. Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.
Wiemer AJ; Yu JS; Shull LW; Barney RJ; Wasko BM; Lamb KM; Hohl RJ; Wiemer DF
Bioorg Med Chem; 2008 Apr; 16(7):3652-60. PubMed ID: 18308574
[TBL] [Abstract][Full Text] [Related]
17. Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform.
Charron G; Li MM; MacDonald MR; Hang HC
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11085-90. PubMed ID: 23776219
[TBL] [Abstract][Full Text] [Related]
18. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
Danesi R; McLellan CA; Myers CE
Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
[TBL] [Abstract][Full Text] [Related]
19. Broadening the Utility of Farnesyltransferase-Catalyzed Protein Labeling Using Norbornene-Tetrazine Click Chemistry.
Auger SA; Venkatachalapathy S; Suazo KFG; Wang Y; Sarkis AW; Bernhagen K; Justyna K; Schaefer JV; Wollack JW; Plückthun A; Li L; Distefano MD
Bioconjug Chem; 2024 Apr; ():. PubMed ID: 38654427
[TBL] [Abstract][Full Text] [Related]
20. Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.
Berndt N; Sebti SM
Nat Protoc; 2011 Oct; 6(11):1775-91. PubMed ID: 22036881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
